Question 1

How many institutions own NBP stock?

Accepted Answer

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own NBP shares is 72, representing 42.36% of the company's common stock.

Question 2

Who are the major shareholders selling NovaBridge Biosciences stock?

Accepted Answer

N/A, in the last quarter, reduced its stake in NBP by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the NBP shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned NBP shares holding by N/A last quarter which brought its holding to - shares worth -.

Question 3

Investors who are buying NBP stock?

Accepted Answer

As per its latest 13F filing, N/A increased its stake in NBP by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of NBP to its portfolio, raising its holding to - shares of worth -. N/A also increased its NBP shares holding by N/A which brought its holding to - shares worth -.

Question 4

NBP's major insiders: who are they?

Accepted Answer

The insider with the most stakes in NBP is Xu Cong Claire , SVP, Clinical Development at the company. Additionally, NBP stock is highly held by See Remarks Hagler Mark Arnold and Chief Medical Officer Dennis Phillip Andrew among others.

Question 5

Did an insider recently sell NBP stock?

Accepted Answer

Company executives, directors, and other insiders own 21.33% percent of NovaBridge Biosciences's stock. Within the last six months, there have been 3 transaction(s) in which NBP insiders have sold stock, totaling 33.39K shares. Insiders that have sold shares include DENNIS PHILLIP ANDREW, XU CONG CLAIRE, and CAO SEAN WUXIONG.

Question 6

Which insider recently purchased NBP stock?

Accepted Answer

There have been 1 transaction(s) during the past 6-months in which NovaBridge Biosciences insiders have bought stock, totalling 230000 shares

Question 7

How much of NBP does insiders own?

Accepted Answer

Around 713.17K NovaBridge Biosciences shares are held by insiders, which represents about 21.33% of NBP stock.

Question 8

Who is the insider with the largest stake?

Accepted Answer

NBP SVP, Clinical Development, Xu Cong Claire holds the largest portfolio of the company's shares. NBP shares owned by Xu total nearly 290.15 thousand.

Question 9

Which institution holds the most shares in NBP?

Accepted Answer

N/A is the largest institutional owner in NBP which holds - shares worth - or N/A of the total NBP shares outstanding followed by N/A with ownership of - shares representing N/A of the NBP ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Question 10

Is NovaBridge Biosciences stock optionable?

Accepted Answer

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the NBP is concerned, it is a stock which is  optionable.

Question 11

Is there a short position on NBP's shares?

Accepted Answer

Number of NBP shares short is 5.48M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

Question 12

About how many outstanding NBP shares are there?

Accepted Answer

As of today, 115.29M shares of NBP are outstanding.

Question 13

Is there many float in NBP stock?

Accepted Answer

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, NBP has 148.83M shares in float.

Question 14

NBP short ratio: what is it?

Accepted Answer

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for NBP is 9.35.

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Jun 18, 2026	DENNIS PHILLIP ANDREW	SALE	0.66	8.49K	5.61K	157.94K
Jun 01, 2026	XU CONG CLAIRE	SALE	3.94	3.49K	13.77K	290.15K
May 14, 2026	CAO SEAN WUXIONG	SALE	1.99	21.4K	42.58K	35.07K
Apr 24, 2026	HAGLER MARK ARNOLD	PURCHASE	2.51	230K	577.3K	230K

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Jun 18, 2026	DENNIS PHILLIP ANDREW	SALE	0.66	8.49K	5.61K	157.94K
Jun 01, 2026	XU CONG CLAIRE	SALE	3.94	3.49K	13.77K	290.15K
May 14, 2026	CAO SEAN WUXIONG	SALE	1.99	21.4K	42.58K	35.07K
Apr 24, 2026	HAGLER MARK ARNOLD	PURCHASE	2.51	230K	577.3K	230K

NBP Stock Ownership Breakdown

NovaBridge Biosciences

Stock Outstanding Shares

Market Insider

Institutional Ownership

Insiders

Buying/Selling by Insiders

Insider Transaction Summary (6 Months)

Frequently Asked Questions